FIELD: medicine.
SUBSTANCE: application of sildenafil trigluconate is proposed as medication for men's erectile disfunction treatment. Invention is characterized by advanced bioavailability of sildenafil trigluconate, which provides erection activation in considerably smaller doses, than for sildenfil citrate.
EFFECT: creation of effective medication for erectile disfunction treatment.
1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ERECTILE OR SEXUAL DISORDERS | 2012 |
|
RU2483742C1 |
| METHOD FOR ERECTILE DYSFUNCTION TREATMENT IN MEN | 2007 |
|
RU2345778C1 |
| COMPOSITION TO MODULATE HUMAN SEXUAL RESPONSE | 1996 |
|
RU2177786C2 |
| COMPOSITION FOR MODULATION OF SEXUAL REACTION OF MAN | 1996 |
|
RU2239424C2 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| METHOD FOR TREATING MALE PATIENTS FOR ERECTILE DYSFUNCTION | 2006 |
|
RU2318516C2 |
| THERAPEUTIC APPROACH TO ERECTILE DYSFUNCTION IN MEN | 2009 |
|
RU2411036C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING SILDENAFIL OR ALPROSTADIL, MINOXIDIL OR EUPHYLLIN, TESTOSTERON OR YOHIMBINE AND LIPOSOMES FOR LOCAL APPLICATION | 2010 |
|
RU2482847C2 |
| METHOD FOR TREATING ERECTILE DYSFUNCTION | 2002 |
|
RU2233183C1 |
| BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR PREVENTION OF MEN'S ERECTILE DYSFUNCTION | 2011 |
|
RU2458537C1 |
